e-SPACE Heart Failure 2022

Published: 19 October 2022

  • Views:

    Views Icon 17465
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.

 

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

 

For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
 

e-SPACE Heart Failure 2022 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day 1

13 sessions
Plenary Session 1: Implementing the 4 foundational therapies in clinical practice Watch now
Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) Watch now
Plenary Session 2: Managing your HF patients with comorbidities (part 1) Watch now
Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Meet the expert: Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 3: Using SGLT2 in your patients: practical considerations Watch now
Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Plenary Session 4: Managing your HF patients with comorbidities (part 2) Watch now
Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Watch now
Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 5: Managing side effects of HF drugs Watch now
Meet the expert: Sex differences in advanced heart failure Watch now
Plenary Session 6: How to manage the obese patient with HF Watch now

Faculty Biographies

Vijay Chopra

Vijay Chopra

Senior Director of Clinical Cardiology, Heart Failure and Research

Dr Vijay Chopra is the Senior Director of Clinical Cardiology, Heart Failure and Research in the Heart Failure Programme at the Max Super Specialty Hospital in Saket, New Delhi, India. He is considered a pioneer in preventive cardiology, and has worked extensively in the management of patients with advanced heart disease. He has been principal investigator of numerous international clinical trials. 

Dr Chopra's research interests include preventive cardiology, heart failures and advanced heart diseases. He was awarded the Kutumbiah Prize in Clinical Medicine from CMC Vellore in 1972. He founded the Heart Failure Association of India (HFAI), and served as its first president from 2014 - 2019. 

Dr Chopra has over 50 publications in peer-reviewed journals. 

Dr Vijay Chopra is an Editorial Board member of Cardiac Failure Review and may be contacted

View full profile

Rishi Sethi

View full profile
Friedrich Koehler

Friedrich Koehler

Head of the Centre for Cardiovascular Telemedicine, Senior Physician at the Medical Department of Cardiology and Angiology

View full profile
Jasper J Brugts

Jasper J Brugts

Heart Failure Cardiologist

Dr Jasper J Brugts is a Heart Failure Cardiologist at Erasmus University Medical Centre, Rotterdam, NL.

He is also a clinical epidemiologist and clinical trialist.

View full profile
William T Abraham

William T Abraham

Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine

Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.

His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair.

Prof Abraham has authored more than 1,000 original works and has been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds.

He received the 2017 Distinguished Scientist Award from the American College of Cardiology.

With his permission, Prof Abraham is contactable here.

View full profile
Leor Perl

Leor Perl

View full profile